Management of Missed First Dose of Hepatitis B Vaccine

Core Principle: Never Restart the Series

The Advisory Committee on Immunization Practices (ACIP) provides clear guidance that applies universally to all hepatitis B vaccine schedules: when any hepatitis B vaccine schedule is interrupted, the series does not need to be restarted 1, 2
The delayed first dose should be administered as soon as possible, and subsequent doses should follow the appropriate intervals from that point 1, 2
This principle is based on immunologic memory—the immune system retains memory of previous vaccine doses even with extended intervals between doses 2

For the standard 3-dose series (Engerix-B, Recombivax HB), the schedule is 0, 1, and 6 months 1
For Heplisav-B (2-dose series), the schedule is 0 and 1 month for adults ≥18 years 2
For Twinrix (combination hepatitis A/B), the accelerated schedule is 0, 7, 21-30 days, and 12 months 3

Do not restart the series even if months or years have passed since the intended first dose—this wastes vaccine and delays protection 1, 2
Do not give inadequate doses or use shorter-than-recommended intervals between subsequent doses, as these must be readministered 1
Do not delay vaccination further while waiting for "optimal timing"—protection begins with the first dose 1

Healthcare personnel who may have occupational exposure to blood or body fluids should initiate the delayed series urgently 1
Hemodialysis patients require higher doses and annual anti-HBs monitoring 1
Persons born in countries with HBV endemicity ≥2% should initiate the delayed series urgently 1
Household or sexual contacts of HBsAg-positive persons should initiate the delayed series urgently 1

Test anti-HBs levels 1-2 months after the final dose for high-risk groups including healthcare personnel, hemodialysis patients, and other immunocompromised individuals 2, 4
Seroprotection is defined as anti-HBs ≥10 mIU/mL 4
If non-response occurs (anti-HBs <10 mIU/mL), consider revaccination with Heplisav-B or high-dose Engerix-B 4